| Issue Number
28, April 15, 2005 |
| |
| Contents of this Issue |
|
|
|
ABBREVIATIONS: ACIP, Advisory Committee on Immunization Practices; CDC, Centers
for Disease Control and Prevention; DVH, Division of Viral Hepatitis; HAV,
hepatitis A virus; HBV, hepatitis B virus; HCV, hepatitis C virus; IAC,
Immunization Action Coalition; IDU, injection drug user; MMWR, Morbidity and
Mortality Weekly Report; MSM, men who have sex with men; STD, sexually
transmitted disease; VIS, Vaccine Information Statement; WHO, World Health
Organization.
----------------------------------------------------------------
(1 of 11)
April 15, 2005
FDA APPROVES NEW TREATMENT FOR HEPATITIS B VIRUS INFECTION
[The following is cross posted from the Immunization Action Coalition's "IAC
EXPRESS" electronic newsletter, 04/04/05.]
On March 29, Bristol-Myers Squibb Company of Princeton, NJ, issued a press
release announcing that FDA approved the company's drug Baraclude (entecavir)
for the treatment of chronic hepatitis B virus (HBV) infection in adults. The
drug is an oral antiviral therapy designed to block replication of HBV in the
body by interfering with the virus's ability to infect cells. It will be
available in the United States as early as April 8.
To access prescribing information from the FDA website, go to:
http://www.fda.gov/cder/foi/label/2005/021797,021798lbl.pdf
----------------------------------------------------------------
Return to top(2 of 11)
April 15, 2005
MAY IS NATIONAL HEPATITIS AWARENESS MONTH
May has been designated National Hepatitis Awareness Month, a time to educate
the public, members of the media, elected officials, and healthcare
professionals about viral hepatitis.
Beginning in May, visit the Division of Viral Hepatitis website at
http://www.cdc.gov/hepatitis to
view information regarding activities planned for this occasion.
----------------------------------------------------------------
Return to top
(3 of 11)
April 15, 2005
NEW: THE CDC-INFO CONTACT CENTER NOW ANSWERS PHONE-IN IMMUNIZATION QUESTIONS;
VISs ARE CHANGED ACCORDINGLY
[The following is cross posted from the Immunization Action Coalition's "IAC
EXPRESS" electronic newsletter, 03/21/05.]
Effective March 15, a new service, the CDC-INFO Contact Center, began answering
immunization questions placed by phone from the public and health professionals.
Previously, the National Immunization Information Hotline answered phone-in
immunization questions.
The new contact center phone number is (800) 232-4636 (i.e., [800] CDC-INFO).
Both English- and Spanish-speaking callers can get information from the contact
center; the first message callers hear is the option to select English or
Spanish. For the next few months, calls placed to the old hotline number will
roll over to the new contact center number. NIP staff is still answering email
immunization questions sent to
nipinfo@cdc.gov
PLEASE NOTE: The new contact center service is not dedicated to immunization; it
is an integrated CDC hotline service that answers questions on many topics.
Callers to the contact center will pick among several options, one of which is
immunization.
HOTLINE NUMBER CHANGES ON VISs
All VISs that contained the old hotline number have been changed to show the new
contact center number. The change was made to VISs in the section titled "How
Can I Learn More?" The VIS dates have not changed; the only change is to the
telephone number. Because the new contact center service will handle calls made
to the old hotline number for a few months, there is no need to discard stocks
of VISs that have the old number.
To access English-language VISs updated with the new contact center number, go
to:
http://www.cdc.gov/nip/publications/VIS/default.htm
To access updated VISs in English and 31 additional languages, go to IAC's VIS
web section at
http://www.immunize.org/vis
**********************
GRATITUDE FOR THE NATIONAL IMMUNIZATION INFORMATION HOTLINE
Operated since 1997 by the American Social Health Association of Research
Triangle Park, NC, the National Immunization Information Hotline earned the
respect and praise of Dr. William L. Atkinson. In speaking about the hotline,
Atkinson, a medical epidemiologist with NIP, said the following:
"I have personally worked with the hotline supervisors and staff almost
continuously since the beginning. Together we have worked through vaccine
shortages, new vaccines, anthrax, smallpox, thimerosal, hurricanes, snowstorms,
blackouts, and many other immunization crises. The hotline supervisors and
staff, past and present, always rose to the challenges we faced. They have been
a trusted source of immunization information for both the public and providers.
I am proud to have had the opportunity to work with such a fine group of people.
I know I speak for all of us at the National Immunization Program when I thank
the National Immunization Information Hotline and the American Social Health
Association for their service to this country. We wish them success in their
post-hotline endeavors."
**********************
----------------------------------------------------------------
Return to top
(4 of 11)
April 15, 2005
NATIONAL VIRAL HEPATITIS PREVENTION CONFERENCE ABSTRACTS DUE MAY 27
Abstracts are being solicited for presentation at the National Viral Hepatitis
Prevention Conference, which will be held December 5-9, 2005, in Washington,
D.C.
The theme for the conference is "Viral Hepatitis Prevention at All Stages of
Life." Presentations will be organized into the following six tracks:
- Perinatal and infant hepatitis B prevention
- Viral hepatitis prevention for children
- Viral hepatitis prevention for
adolescents/high-risk youth
- Viral hepatitis prevention for adults;
delivering, implementing, and evaluating prevention and control strategies and
services
- Education, training, and outreach for viral
hepatitis prevention and control
- Other/cross cutting: hepatitis prevention and
control
Abstract submission deadline is
Friday, May 27, 2005, midnight Pacific Time.
For more information, visit the conference website at
http://www.nvhpc.com
----------------------------------------------------------------
Return to top
(5 of 11)
April 15, 2005
NASTAD'S APRIL "HIV PREVENTION BULLETIN" FOCUSES ON HEPATITIS
The April 2005 issue of the "HIV
Prevention Bulletin" published by NASTAD (National Alliance of State and
Territorial AIDS Directors) focuses on integrating viral hepatitis prevention
services into HIV/AIDS programs.
The introduction states: "Over the past several years, hepatitis A, B, and C
have received growing attention, as health department HIV/AIDS programs and HIV
prevention and care community-based organizations (CBOs) learn that their
clients also are at risk of or infected with viral hepatitis. Current estimates
suggest that at least 4 million Americans have ever been infected with hepatitis
C, 2.7 million are chronically infected, and at least 25% of persons living with
HIV/AIDS are co-infected with the disease. Further, hepatitis C related
complications are now emerging as the leading cause of death among persons
living with HIV/AIDS. Periodic outbreaks of hepatitis A and B virus infections
have also served as a reminder that men who have sex with men (MSM), drug users,
persons with multiple sex partners, and persons with a history of STDs are at
risk of infection from these vaccine-preventable diseases. . . Despite the
limitations of federal resources, health departments, national organizations,
and CBOs are working together to address viral hepatitis in their communities."
The issue highlights five programs demonstrating "collaboration in action," and
provides information on advocacy, treatment, resources, conferences, and more.
To read the April "HIV Prevention Bulletin," click
here.
The "HIV Prevention Bulletin" is
free and often includes information about viral hepatitis in groups at risk. To
receive this electronic publication, please send an email to:
nastad@nastad.org
Please provide your name, position, agency, address, email address, and phone
number.
----------------------------------------------------------------
Return to top
(6 of 11)
April 15, 2005
IAC UPDATES MULTIPLE PRINT PIECES RELATED TO VIRAL HEPATITIS
IAC recently updated several of its print pieces, primarily to take into account
the recently licensed treatment option, entecavir. Following is a list of pieces
updated in April 2005.
(1) "Hepatitis A, B, and C: Learn the Differences"
To access a ready-to-print (PDF) version, go to:
http://www.immunize.org/catg.d/p4075abc.pdf
To access a web-text (HTML) version, go to:
http://www.immunize.org/catg.d/p4075abc.htm
(2) "If you have chronic hepatitis B (HBV) infection... "
To access a ready-to-print (PDF) version, go to:
http://www.immunize.org/catg.d/p4120eng.pdf
To access a web-text (HTML) version, go to:
http://www.immunize.org/catg.d/p4120.htm
(3) "Management of Chronic Hepatitis B Infection in Adults" by Brian McMahon, MD
To access a ready-to-print (PDF) version, go to:
http://www.immunize.org/catg.d/p2161.pdf
To access a web-text (HTML) version, go to:
http://www.immunize.org/catg.d/p2161.htm
(4) "What the Physician Can Do to Help the Child with Chronic Hepatitis B Virus
Infection" by Sarah Jane Schwarzenberg, MD
To access a ready-to-print (PDF) version, go to:
http://www.immunize.org/catg.d/p2170sjs.pdf
To access a web-text (HTML) version, go to:
http://www.immunize.org/catg.d/p2170.htm
(5) "You are not alone! Information for young adults who are chronically
infected with hepatitis B virus" by Sarah Jane Schwarzenberg, MD, and Karen
Wainwright, RN, BS, CCRA
To access a ready-to-print (PDF) version, go to:
http://www.immunize.org/catg.d/4118.pdf
To access a web-text (HTML) version, go to:
http://www.immunize.org/catg.d/4118.htm
(6) "Brief Introduction to Hepatitis B for Parents of Adopted Children" by Sarah
Jane Schwarzenberg, MD
To access a ready-to-print (PDF)
version, go to:
http://www.immunize.org/catg.d/4150intr.pdf
To access a web-text (HTML) version, go to:
http://www.immunize.org/catg.d/4150intr.htm
(7) "Does your patient have chronic hepatitis B?" by Coleman Smith, MD
To access a ready-to-print (PDF) version, go to:
http://www.immunize.org/catg.d/p2162.pdf
To access a web-text (HTML) version, go to:
http://www.immunize.org/nslt.d/n18/p2162.htm
In addition, five recently revised viral hepatitis pieces were re-translated
into Turkish, thanks to Drs. Mustafa Kozanoglu and Murat Serbest of Adana,
Turkey.
"Hepatitis A, B, and C: Learn the Differences"
http://www.immunize.org/catg.d/p4075tu.pdf
"Protect yourself against hepatitis A and hepatitis B. . . a guide for gay and
bisexual men"
http://www.immunize.org/catg.d/p4115tu.pdf
"If you have chronic hepatitis B (HBV) infection. . ."
http://www.immunize.org/catg.d/p4120tu.pdf
"Should you be vaccinated against hepatitis A?"
http://www.immunize.org/catg.d/p2190tu.pdf
"Should you be vaccinated against hepatitis B?"
http://www.immunize.org/catg.d/p2191tu.pdf
----------------------------------------------------------------
Return to top
(7 of 11)
April 15, 2005
HEPATITIS B FOUNDATION PUBLISHES WINTER 2005 ISSUE OF "B INFORMED"
The Winter 2005 issue of "B Informed," the newsletter of the Hepatitis B
Foundation (HBF) is now available online. This issue includes articles on HBF's
new research institute and a thought-provoking article about the state of HBV
research funding.
The current issue of "B Informed" can be accessed at
http://www.hepb.org/pdf/hepbnews42.pdf
To receive "B Informed" through the U.S. mail, please send your name and full
address to info@hepb.org and HBF will
add your name to their confidential mailing list.
The HBF website offers many other resources, including the continually updated "HBF
Drug Watch." To access the home page go to:
http://www.hepb.org
----------------------------------------------------------------
Return to top
(8 of 11)
April 15, 2005
FDA APPROVES NEW HAV ASSAY TEST
On March 7, 2005, the U.S. Food and Drug Administration (FDA) approved Bayer
HealthCare Diagnostics' ADVIA Centaur® HAV Total Assay, an in vitro diagnostic
immunoassay for the qualitative determination of total antibodies to the
hepatitis A virus in human serum or plasma. The assay can be used by
laboratories to aid in the diagnosis of previous or ongoing HAV infection or in
the identification of HAV-susceptible individuals for vaccination.
To access the New Device Approval information from the FDA website, go to:
http://www.fda.gov/cdrh/mda/docs/p040017.html
----------------------------------------------------------------
Return to top
(9 of 11)
April 15, 2005
HBF'S B-INFORMED PATIENT CONFERENCE TO BE HELD JULY 9-10
The Hepatitis B Foundation (HBF) will be sponsoring the fifth B-Informed Patient
Conference on July 9-10, 2005. The conference will be held at Delaware Valley
College, Doylestown, Pennsylvania.
For more information, go to http://www.hepb.org,
call (215) 489-4900, or email info@hepb.org
--------------------------------------------------------------
Return to top
(10 of 11)
April 15, 2005
RECOMMENDATIONS FOR IMPROVING HIGH-RISK ADULTS' INFLUENZA, PPV, AND HEPATITIS B
VACCINATION COVERAGE NOW AVAILABLE
[The following is cross posted from the Immunization Action Coalition's "IAC
EXPRESS" electronic newsletter, 04/04/05.]
On April 1, CDC issued "Improving Influenza, Pneumococcal Polysaccharide, and
Hepatitis B Vaccination Coverage Among Adults Aged <65 Years at High Risk: A
Report on Recommendations of the Task Force on Community Preventive Services,"
as a Recommendation and Reports issue of MMWR. The summary is reprinted below.
***********************
The Task Force on Community Preventive Services conducted systematic reviews to
evaluate the effectiveness of interventions to improve targeted vaccination
coverage (i.e., coverage with vaccines recommended for some but not all persons
in an age range on the basis of risk for exposure or disease) among adults aged
<65 years at high risk when implemented alone (single-component interventions)
and in combination with other interventions (multicomponent interventions). A
1999 report by the Task Force examined the effectiveness of interventions to
increase coverage with universally recommended vaccinations (i.e., vaccines
recommended for all persons in particular age groups). Three targeted
vaccinations recommended for populations at risk are addressed in this review:
influenza, pneumococcal polysaccharide, and hepatitis B. The Task Force
identified evidence that certain combinations of interventions have improved
vaccination coverage. To increase targeted vaccination coverage, the Task Force
recommends a combination of interventions that include selected interventions
from two or three categories of interventions (i.e., increasing community demand
for vaccinations, enhancing access to vaccination services, and provider- or
system-based interventions). The Task Force also recommends provider reminders,
when implemented alone, to improve targeted vaccination coverage. This report
provides additional information about population-based interventions to improve
the coverage of influenza, pneumococcal polysaccharide, and hepatitis B vaccines
among populations at risk, briefly describes how the reviews were conducted, and
provides information that can help in applying the interventions locally.
***********************
To access a web-text (HTML) version of the recommendation, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5405a1.htm
To access a ready-to-print (PDF) version of the recommendation, go to:
http://www.cdc.gov/mmwr/PDF/rr/rr5405.pdf
To receive a FREE electronic subscription to MMWR, go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html
----------------------------------------------------------------
Return to top
(11 of 11)
April 15, 2005
NEW MEETING INFORMATION AVAILABLE ON VHPB WEBSITE
The Viral Hepatitis Prevention Board (VHPB) website has been updated to include
information from the March meeting held in Rome: "Hepatitis B, Hepatitis C, and
Other Blood-Borne Infections in Healthcare Workers."
Topics covered during the meeting included global epidemiology of blood-borne
infections in healthcare workers, transmission of HBV and HCV as an occupational
risk, primary and secondary prevention measures against HBV and HCV infections
in healthcare workers, and recommendations for HBV-, HCV-, or HIV-infected
healthcare workers or (para)medical students.
To access the meeting program and most of the presentations, go to:
http://www.vhpb.org
|